Trends in global glucose lowering medication consumption: Insights from pharmaceutical sales data (2010–2021)

Myo Myo Swe Oo, Sahan Jayawardana, Allen Campbell, Murray Aitken, Kershaw V Patel, Khuram Nasir, Mandeep Mehra and Elias Mossialos

PLOS Global Public Health, 2025, vol. 5, issue 10, 1-19

Abstract: Diabetes imposes a substantial global burden. Examining consumption trends of glucose lowering medications can help facilitate cross-country comparisons and uncover areas of unmet need. Leveraging IQVIA MIDAS data, our analysis spans 72 countries and 2 regions from 2010 to 2021, employing defined daily dose (DDD) as a consumption metric. We assessed consumption trends across income tiers and individual country rankings, exploring WHO essential medicines, insulin, new drug classes and specific drugs, with further analyses on their correlation with treatment guideline releases. Global glucose lowering medication consumption rate increased from 39.2 to 54.0 DDD per thousand inhabitants per day (DDD/TID) between 2010 and 2021. Across the same period, median consumption rates were 60.1 DDD/TID [IQR, 46.5-70.6] in high-income countries (HICs), 26.9 DDD/TID [IQR, 8.0-51.3] in upper-middle income countries (UMICs) and 10.8 DDD/TID [IQR, 6.5-18.5] in low- and lower-middle income countries (LMICs). While the most significant consumption changes occurred in UMICs and LMICs such as Bosnia, China and Indonesia, HICs such as Finland, Canada and USA consistently showed the highest consumption rates. Over the study period, the median consumption rates for essential medicines, insulin and new drug classes increased, except for intermediate-acting insulin and soluble insulin/biosimilars. HICs drove the consumption of fast-acting and long-acting insulin and new drug classes, whereas UMICs and LMICs drove the consumption of intermediate-acting insulin. This study sheds light on the global variations in glucose lowering medication consumption, providing insights to address access gaps, particularly in UMICs and LMICs.

Date: 2025
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/globalpublichealth/artic ... journal.pgph.0005326 (text/html)
https://journals.plos.org/globalpublichealth/artic ... 05326&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pgph00:0005326

DOI: 10.1371/journal.pgph.0005326

Access Statistics for this article

More articles in PLOS Global Public Health from Public Library of Science
Bibliographic data for series maintained by globalpubhealth ().